Adagio Therapeutics, Inc. (ADGI): Price and Financial Metrics
ADGI Price/Volume Stats
| Current price | $4.64 | 52-week high | $78.82 |
| Prev. close | $4.60 | 52-week low | $2.41 |
| Day low | $4.40 | Volume | 536,300 |
| Day high | $4.74 | Avg. volume | 2,269,922 |
| 50-day MA | $4.13 | Dividend yield | N/A |
| 200-day MA | $6.92 | Market Cap | 504.98M |
ADGI Stock Price Chart Interactive Chart >
Adagio Therapeutics, Inc. (ADGI) Company Bio
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Its lead product candidate is the ADG20, a neutralizing antibody that is in Phase II/III clinical trials for the treatment and prevention of coronavirus disease. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. Adagio Therapeutics, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts.
ADGI Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...